Methods: Five trainees (one staff radiologist and four 4 th year OB/GYN residents) participated in this study. All trainees had experience on performing TVS, but none of them had specific training on the assessment of myometrial infiltration in cases of endometrial cancer. Training program consisted of two parts. In part one, trainees were given one specific lecture and watched video clips from ten cases explained by the trainer. The method taught for assessing myometrial infiltration was based on the subjective impression. In part two, all trainees had to visualise 50 video clips of TVS assessment of the uterus from cases of endometrial cancer already treated surgically. Definitive histology was used as reference standard. All trainees had to state whether myometrial infiltration was > 50% or < 50%. After visualising each video clip the trainee was informed whether she/he was right or wrong regarding myometrial infiltration. In case of mistake, the video clip was revised with the trainer to learn why the mistake. This feedback was considered as essential in the process of learning. All trainees performed their evaluations blinded each other. LC-CUSUM and standard CUSUM graphics were plotted to determine how many cases were needed to reach competency, allowing a mistake rate of 15% (accuracy reported for expert examiners is about 85%), and to determine whether competency is maintained after reaching Objectives: Uterine sarcoma is a rare disease with a poor prognosis, and its preoperative diagnosis is difficult. We previously presented the finding that a tumour with high tumour-to-subcutaneous fat signal intensity ratio on MRI T2 weighted imaging (TFSIR) and low ADC is highly suspected of sarcoma. But we have not reported our experience of clinical use as a preoperative prediction method yet. This time we re-examined the cut-off value of these parameters. The purpose of this study is to testify that these parameters are worthy of clinical use. Methods: MRI was performed in five cases of uterine sarcoma from 2014 for three years (sarcoma group), and in 64 cases of uterine benign tumour in 2015 and 2016 (myoma group) at our hospital. TFSIR and ADC were calculated and compared between two groups. The cut-off values of these parameters to predict sarcoma were also calculated. Then, preoperative prediction method by combination of these two parameters was considered. Finally, we applied this method for 38 uterine tumours in 2017 preoperatively, and matched the predictions to pathological results. Results: The sarcoma group had significantly higher TFSIR than the myoma group (p<0.001). The minimum cut-off value of TFSIR to diagnose sarcoma was 0.515 (sensitivity: 100%, specificity: 88%). The sarcoma group had significantly lower ADC values than the leiomyoma group (p<0.001). The maximum cut-off value of ADC to diagnose sarcoma was 1.280 (sensitivity: 100%, specificity: 84%). All tumours with both positive TFSIR and ADC were sarcoma. The others ware benign tumour. We considered that tumour with both positive TFSIR and ADC is predicted as sarcoma. Among 38 uterine tumours in 2017, three tumours were predicted as sarcoma and two of those tumours were indeed sarcoma. Thus one false positive case resulted. All tumours predicted as benign tumour were indeed benign. Conclusions: Preoperative prediction of uterine sarcoma is possible using both TFSIR and ADC scores on MRI, whereas we have to be careful for false positive case.
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Clinical and ultrasound characteristics of malignant ovarian masses in pregnant women Methods: This is a retrospective study. Twenty-two women with a histological diagnosis of malignant ovarian mass detected during pregnancy and with a preoperative ultrasound examination were identified between 2000 and 2017. Ultrasound characteristics of the lesions were described by using the terms of the International Ovarian Tumor Analysis (IOTA) group. Results: The median age was 32.5 (range, 23-42) years old. 2/22 (9%) patients had a mucinous borderline tumour, 8/22 (36.4%) had a serous or endocervical-type borderline tumour, 7/22 (31.8%) had a primary epithelial ovarian carcinoma and 5/22 (22.8%) had a metastatic tumour to the ovary. On ultrasound, mucinous ovarian borderline tumours were described as multilocular (1/2,50%) or multilocular-solid (1/2,50%) lesions, with a minimal vascularisation. Serous/endocervical-type borderline tumours were described as unilocular-solid (3/8, 37.5%) or multilocular-solid (5/8, 62.5%) masses and all of them had papillary projections. The vast majority of the invasive epithelial ovarian cancers were described as multilocular-solid masses (5/7, 71.4%), whereas 1/7 (14.3%) was unilocular-solid and 1/7 (14.3%) was described as solid mass, presenting papillary projections in 3/7 (42.9%) cases; most of the epithelial ovarian carcinomas (5/7, 71.4%) were moderately or highly vascularised. All metastatic tumours (5/5, 100%) appeared as solid masses and 4/5 (80%) had a high vascularisation. Conclusions: Malignant ovarian masses in pregnancy represent a rare pathological condition. On ultrasound examination, the morphological features are similar to those described in non-pregnant patients.
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Comparison of decreased blood flow detected by ultrasound with pathological findings in patients with neoadjuvant chemotherapy in cervical carcinoma 
